TERM ID="NYU_TERM_1" STRING="Canakinumab" FREQUENCY=1 START=66 END=77 LEMMA="CANAKINUMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Difficult-to-Treat" FREQUENCY=1 START=95 END=113 LEMMA="DIFFICULT-TO-TREAT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="Difficult-to-Treat Gouty Arthritis Canakinumab" FREQUENCY=1 START=95 END=141 LEMMA="GOUTY ARTHRITIS CANAKINUMAB DIFFICULT-TO-TREAT" LEMMA_FREQUENCY=1 HEAD_TERM="Gouty Arthritis Canakinumab" HEAD_LEMMA="GOUTY ARTHRITIS CANAKINUMAB"
TERM ID="NYU_TERM_4" STRING="Gouty Arthritis Canakinumab" FREQUENCY=1 START=114 END=141 LEMMA="GOUTY ARTHRITIS CANAKINUMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="Practical Clinical Considerations" FREQUENCY=1 START=17 END=50 LEMMA="PRACTICAL CLINICAL CONSIDERATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="arthritis attacks" FREQUENCY=1 START=188 END=205 LEMMA="ARTHRITIS ATTACK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="canakinumab treatment" FREQUENCY=1 START=533 END=554 LEMMA="CANAKINUMAB TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="clinical considerations" FREQUENCY=1 START=568 END=591 LEMMA="CLINICAL CONSIDERATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="potential contraindications" FREQUENCY=1 START=384 END=411 LEMMA="POTENTIAL CONTRAINDICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="standard-of-care medication" FREQUENCY=1 START=233 END=260 LEMMA="STANDARD-OF-CARE MEDICATION" LEMMA_FREQUENCY=1
